Evidence map›Paper›PMID 42800816›Full record

ArticleNature communications2026

SpaCEy links spatial tissue patterns to clinical outcomes using explainable graph neural networks.

Ahmet Sureyya Rifaioglu, Egle Helene Ervin, Ahmet Sarigun, Deniz Germen, Bernd Bodenmiller, Jovan Tanevski, Julio Saez-Rodriguez

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmet Sureyya RifaiogluInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.
Egle Helene ErvinDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Ahmet SarigunBioinformatics and Omics Data Science Platform, Max Delbruck Center for Molecular Medicine - Berlin Institute for Molecular Systems Biology, Berlin, Germany.ORCID http://orcid.org/0009-0003-2715-5344
Deniz GermenDepartment of Computer Engineering, Middle East Technical University, Ankara, Türkiye.
Bernd BodenmillerDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6325-7861
Jovan TanevskiInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany. jovan.tanevski@uni-heidelberg.de.ORCID http://orcid.org/0000-0001-7177-1003
Julio Saez-RodriguezInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany. saezlab@ebi.ac.uk.ORCID http://orcid.org/0000-0002-8552-8976

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissues are complex ecosystems organised in space, and alterations in this organisation underpin multiple diseases. Spatial omics enables molecular profiling of tissue organisation, but linking these patterns to clinical outcomes remains challenging. We present SpaCEy (Spatial Clinical Explainability), an explainable graph neural network that identifies tissue patterns predictive of clinical outcomes in spatial proteomics datasets. SpaCEy models tissues as spatial graphs from molecular marker expression, without using predefined cell-type labels or anatomical regions as model inputs. Its embeddings capture intercellular relationships and molecular dependencies for predicting overall survival and disease progression. An integrated explainer identifies recurring spatial patterns and coordinated marker expression relevant to model predictions. Applied to a spatial proteomic lung cancer cohort, SpaCEy identifies spatial and protein-expression patterns associated with disease progression. Across multiple breast cancer proteomic datasets, it stratifies patients by overall survival, both across and within established clinical subtypes, and highlights protein markers underlying this stratification.

Indexed as

Breast NeoplasmsLung NeoplasmsBiomarkers, TumorDisease ProgressionFemaleGraph Neural NetworksHumansProteomicsBiomarkers, Tumor

Identifiers

PMID42800816
PMCPMC13615965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.